All Online

529 - 540 of 569 results

Refine

Active filters

Vitamin D and COVID-19 - Frankly Speaking EP 187

Guest: Alan Ehrlich MD, FAAFPMusic Credit: Richard Onorato

This podcast will review what is known and theorized about vitamin D status, susceptibility to viral infections, and mortality from viral infections.


0.25 CME CREDIT

Red Meat: Confusion and Conflicts of Interest - Frankly Speaking EP 150

Guest: Robert A. Baldor, MD, FAAFPMusic Credit: Richard Onorato

0.25 CME

Join us as we review a landmark paper that reached the conclusion that limiting red meat would not have a large impact on patient outcomes.


Continuous glucose monitoring (CGM) is at the forefront of new diabetes technologies and can lead to improved care for many people, but the expanding market challenges primary care clinicians to keep up with guidelines on how and when to use personal and professional CGM devices. This curriculum, developed in partnership with the Association of Diabetes Care and Education Specialists (ADCES), will educate clinicians on how to identify people who are candidates for CGM, interpret CGM data, and adjust treatment plans, while effectively involving patients in these decisions. These practical strategies and insights for using CGM will help transform this new technology from a specialty-based tool to an integral part of diabetes management in the primary care setting. You can earn up to 2.0 CME/CE credits in total by completing all 3 of the modules in this curriculum. Two podcasts are also included that are designed to share with patients who want to know more about CGM; they do not qualify for CME/CE credit. This curriculum includes: • A series of 3 text-based adaptive learning modules • 2 Patient education podcasts (~15-20 minutes each)


0.25 CME CREDIT

Treating Type 2 Diabetes Mellitus – A Clearer Framework - Frankly Speaking EP 204

Guest: Robert Baldor, MD, FAAFPMusic Credit: Richard Onorato

0.25 CME

The American Diabetes Association (ADA) has recently updated their guidelines for pharmacologic management of T2DM which addresses patients with various co-morbid conditions. This episode will overview these guidelines to help primary care clinicians hone treatment of their patients with T2DM.


0.25 CME CREDIT

Transgender Care: Breaking the Barriers and Acknowledging Bias - Frankly Speaking EP 149

Guest: Jill Terrien PhD, ANP-BCMusic Credit: Richard Onorato

0.25 CME

Join us as we discuss best practices for providing care to the transgender population.


0.25 CME CREDIT

Heads Up! 2020 Guideline Update on Cervical Cancer Screening - Frankly Speaking EP 193

Guest: Jill Terrien PhD, ANP-BCMusic Credit: Richard Onorato

0.25 CME

Join us as we discuss the American Cancer Society 2020 guideline update on cervical cancer screening for women of average risk.


0.25 CME CREDIT

No Good Reason to Go Nuts Over Coconut Oil - Frankly Speaking EP 203

Guest: Jill Terrien, PhD, ANP-BCMusic Credit: Richard Onorato

0.25 CME

Join us as we discuss the risks of elevated cholesterol when consuming coconut oil.


0.5 CME CREDIT

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss trends in substance use throughout the pandemic and common clinical questions about thrombosis and antithrombotic therapy in patients with SARS-CoV-2 infection.


Senior man swallowing pill
0.5 CME CREDIT

What PCPs Need to Know About Influenza Treatment (Module 2)

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.50 CME/MOC
0.40 AANP | 0.20 Pharmacology

In recent years, a new first-in-class antiviral emerged that expanded the arsenal of effective treatments for influenza. But do you know when to prescribe these therapies and which ones are most appropriate for each individual patient? Research has shown that only a fraction of patients at severe risk for influenza-related complications receive an antiviral medication within the appropriate timeframe of symptom onset. Before you see your next patient with influenza, you need to participate in this short and innovative video-based activity that is designed to enhance learning and keep you engaged. You will walk away with guideline-recommended strategies to appropriately initiate antiviral treatment for known or suspected influenza.


Physician checking on elder patient sitting on wheelchair
0.32 CME CREDIT

What PCPs Need to Know About Influenza Chemoprophylaxis (Module 3)

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.25 CME/MOC
0.32 AANP | 0.16 Pharmacology

In clinical trials, prophylactic treatment given at the start of an outbreak demonstrates a 60% to 90% reduction in the risk of developing influenza. However, identifying which patients would benefit most from influenza prophylaxis with antivirals is challenging. We’ll share with you clear guidance from the CDC to help you make the appropriate chemoprophylaxis decisions. After this short session, you’ll be able to identify patients who would be good candidates for antiviral prophylaxis and choose medications that best fit each patient. Before you see your next patient, you need to participate in this brief and innovative video-based activity that is designed to enhance learning and keep you engaged.


0.25 CME CREDIT

What’s New in Influenza Management? (Module 4)

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.25 CME/MOC
0.25 AANP | 0.07 Pharmacology

Are you aware of the recent updates in the prevention, testing, and treatment of influenza? This brief module arms you with the most important updates you’ll need to protect your patients in this upcoming influenza season. You’ll hear about the newly available quadrivalent high-dose influenza vaccine and the recently FDA-approved therapy that could potentially improve efficacy and treatment adherence while reducing transmission of influenza. You’ll also walk away with proven approaches to testing patients with acute respiratory illness—hint: it depends on what’s circulating in the community. Before you see your next patient, read through this innovative infographic that is enhanced with audio clips, questions, and additional references to enhance your learning and keep you engaged.


girl, blowing her nose in bed speaking with physician virtually
0.36 CME CREDIT

What PCPs Need to Know About Influenza Testing (Module 1)

An Interactive Learning ExperienceThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

0.25 CME/MOC
0.36 AANP

Do you know when to order influenza testing (and which test) before initiating treatment in patients with influenza? Can you confidently differentiate influenza from SARS-CoV-2 infection? And can you easily identify high-risk patients who would benefit from influenza treatment or prophylaxis? Given the high cost of influenza-related morbidity and mortality to individuals and society, you have to get it right. This session will answer these questions and more and give you the confidence to accurately diagnose patients with influenza. Before you see your next patient with acute respiratory symptoms, you need to participate in this brief and innovative video-based activity that is designed to enhance learning and keep you engaged.